Clarity Pharmaceuticals Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2018 - 2020
Net Income	-64.3	-42.32	-24.6	-23.75	-10.22	Upgrade
Depreciation & Amortization	0.19	0.15	0.1	0.05	0.02	Upgrade
Loss (Gain) From Sale of Assets	-	0	-	-	0	Upgrade
Stock-Based Compensation	6.12	4.17	1.25	8.77	2.07	Upgrade
Other Operating Activities	-	-	-	0	-	Upgrade
Change in Accounts Receivable	2.54	-2.63	-3.34	-3.29	-0.71	Upgrade
Change in Accounts Payable	1.57	0.26	0.02	5.01	1.07	Upgrade
Change in Unearned Revenue	-	-	-	-0.08	-0.03	Upgrade
Change in Other Net Operating Assets	-0.89	-2.87	-0.92	-0.01	0.13	Upgrade
Operating Cash Flow	-54.77	-43.24	-27.5	-13.31	-7.68	Upgrade
Capital Expenditures	-0.18	-0.5	-0.05	-0.21	-0.06	Upgrade
Investment in Securities	52.17	-54.8	3.2	-26.5	-9.5	Upgrade
Investing Cash Flow	51.99	-55.31	3.15	-26.71	-9.56	Upgrade
Issuance of Common Stock	2.4	121.86	0.24	92.53	21.1	Upgrade
Other Financing Activities	-0.19	-6.65	-0.01	-5.6	-0.68	Upgrade
Financing Cash Flow	2.21	115.21	0.23	86.93	20.41	Upgrade
Foreign Exchange Rate Adjustments	0.35	0.02	-0.01	-0	-0	Upgrade
Miscellaneous Cash Flow Adjustments	-0	-	-	-	-	Upgrade
Net Cash Flow	-0.22	16.69	-24.12	46.9	3.17	Upgrade
Free Cash Flow	-54.95	-43.74	-27.55	-13.53	-7.74	Upgrade
Free Cash Flow Margin	-580.71%	-380.14%	-281.07%	-209.43%	-242.06%	Upgrade
Free Cash Flow Per Share	-0.17	-0.16	-0.11	-0.06	-0.04	Upgrade
Cash Interest Paid	-	-	-	-	0	Upgrade
Cash Income Tax Paid	0.72	0.08	0.1	0.02	-	Upgrade
Levered Free Cash Flow	-33.7	-29.16	-19.59	-7.23	-3.9	Upgrade
Unlevered Free Cash Flow	-33.7	-29.16	-19.59	-7.23	-3.9	Upgrade
Change in Working Capital	3.22	-5.24	-4.25	1.63	0.46	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.